SCHEMBL18633830

SCHEMBL18633830

C/C=C\C1=C(N)Oc2ccc(C(C)(C)O)cc2/C1=C/CCN1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.34
▸ SIGMAR1 Q99720 3/20 0.32
▸ KCNK2 O95069 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GMNN O75496 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PMP22 Q01453 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18633833 0.85 CCR1 (0.42) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL12121948 0.70 CCR1 (0.68) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL16312668 0.69 CCR1 (0.39) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL15478321 0.69 CCR1 (0.43) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL18633827 0.69 CCR1 (0.39) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL12936668 0.68 CCR1 (0.43) CCR1HRH3SIGMAR1KCNK2USP2
SCHEMBL14579804 0.65 CCR1 (0.48) CCR1TP53
SCHEMBL15478381 0.64 CCR1 (0.38) CCR1SIGMAR1
SCHEMBL13824458 0.62 CCR1 (0.37) CCR1HRH3HRH1
SCHEMBL15478357 0.61 CCR1 (0.63) CCR1SIGMAR1KCNK2USP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1688418-B1 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARM INC (US) 2017-03-15 — — EP disclosed
Send feedback